Retractable Technologies, Inc. (RVP) Stock

Retractable Technologies, Inc. (RVP) is a Healthcare stock trading at $0.72 (as of 2026-08-20), with a market capitalization of $21.61M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Retractable Technologies designs, develops, manufactures, and markets safety syringes and other safety medical products. Its offerings include insulin, tuberculin, allergy antigen, and autodisable syringes, along with related adapters, holders, trays, catheters, needles, and blood collection sets, which it sells to healthcare professionals through distributors and an international network.

Understand Retractable Technologies, Inc.: how it makes money

Retractable Technologies designs and sells safety syringes and other safety medical products, including insulin and specialty syringes and related accessories, to healthcare providers through distribution across the United States, North and South America, and internationally.

The companys near-term profit power appears driven by unit volume, because the latest operating indicators include both 'Overall Unit Sales Decrease' and 'Domestic Revenues Decrease'.

Revenue by segment (latest quarter)
Net Revenue$0.0B

Business quality (Weak): Key operating indicators point to volume and domestic softness, and the latest financial snapshot shows negative gross and operating margins.

Bull case

  • Product breadth across safety syringes and related safety medical devices: The company offers a portfolio that includes VanishPoint insulin syringes, tuberculin, insulin and allergy antigen syringes, safety catheters, blood collection sets, and needle and adapter products.
  • Distribution footprint spans multiple regions: Products are marketed in the United States, across North and South America, and internationally.

Bear case

  • Latest period shows unit and domestic revenue decline: The operating KPIs indicate 'Overall Unit Sales Decrease' and 'Domestic Revenues Decrease' in the latest period.
  • Margins are deeply negative in the latest quarter: For the period ending 2026-03-31, gross margin is -11.7% and operating margin is -85.9%, suggesting operating leverage pressure.
Valuation — source: SEC EDGAR (first-party)
Price$0.72
Market Cap$21.61M
Price / Book0.30
Price / Sales0.64
FCF Yield-20.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$38.27M
Net Margin-32.8%
Revenue Growth (YoY)-31.1%
FCF Growth (YoY)-56.7%
Financial Health — source: SEC EDGAR
Altman Z-Score0.55 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($519409.00)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOThomas J. Shaw
Employees221
CountryUS
IPO Date2001-05-04

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • PAVmed Inc. (PAVM)
  • Accuray Incorporated (ARAY)
  • Plus Therapeutics, Inc. (PSTV)
  • HeartBeam, Inc. (BEAT)
  • Modular Medical, Inc. (MODD)
  • NeuroOne Medical Technologies Corporation (NMTC)
  • Adagio Medical Holdings, Inc. (ADGM)
  • SeaStar Medical Holding Corporation (ICU)
RVP earnings history · RVP institutional & insider holders · RVP KPIs & operating metrics · RVP financials · RVP investor presentations & press releases · RVP SEC filings · RVP peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.